Jecko Thachil, Ning Tang, Satoshi Gando, Anna Falanga, Marcel Levi, Cary Clark, Toshiaki Iba.
J Thromb Haemost. 2020, Online ahead of print.
Publications 2020
DOACs and “Newer” Hemophilia Therapies in COVID-19: Reply
Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T.
J Thromb Haemost. 2020;18(7):1795-1796.
ISTH Interim Guidance on Recognition and Management of Coagulopathy in COVID-19
Thachil J, Tang N, Gando S, Falanga A, Cattaneo M, Levi M, Clark C, Iba T
J Thromb Haemost. 2020;18(5):1023-1026.
Type and Dose of Heparin in Covid-19: Reply
Thachil J, Tang N, Gando S, Falanga A, Levi M, Clark C, Iba T, Cattaneo M.
J Thromb Haemost. 2020. Online ahead of print.
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow-Up: JACC State-of-the-Art Review
Bikdeli B, Madhavan BV, Jimenez D, Chuich T, Dreyfus I, Driggin E, Der Nigoghossian C, Ageno W, Madjid M, Guo Y,Tang LV, Hu Y, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Caprini JA, Tafur AJ, Burton JR, Francese DP, Wang EY, Falanga A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom GW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Steg PG, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH.
J Am Coll Cardiol. 2020 16;75(23):2950-2973.
Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research
6. Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH, Global COVID-19 Thrombosis Collaborative Group. (2020).
Thromb Haemost. 2020;120(7):1004-1024
Venous Thromboembolism Prophylaxis and Treatment in Patients With Cancer: ASCO Clinical Practice Guideline Update
Key NS, Khorana AA, Kuderer NM, Bohlke K, Lee AYY, Arcelus JI, Wong SL, Balaban EP, Flowers CR, Francis CW, Gates LE, Kakkar AK, Levine MN, Liebman HA, Tempero MA, Lyman GH, Falanga A.
J Clin Oncol. 2020;38(5):496-520.
The Prevention and Management of Asparaginase-Related Venous Thromboembolism in Adults: Guidance From the SSC on Hemostasis and Malignancy of the ISTH
Zwicker JI, Wang TF, DeAngelo DJ, Lauw MN, Connors JM, Falanga A, McMasters M, Carrier M
J Thromb Haemost. 2020;18(2):278-284.
Thrombotic Biomarkers for Risk Prediction of Malignant Disease Recurrence in Patients With Early Stage Breast Cancer
Thrombin generation predicts for early recurrence in breast cancer patients
Marchetti M, Giaccherini C, Masci G, Verzeroli C, Russo L, Celio L, Sarmiento R, Gamba S, Tartari CJ, Diani E, Vignoli A, Malighetti P, Spinelli D, Kuderer NM, Nichetti F, Tondini C, Barni S, Giuliani F, Petrelli F, D’Alessio A, Gasparini G, Labianca R, Santoro A, De Braud F, Falanga A; HYPERCAN Investigators.
J Thromb Haemost. 2020. Online ahead of print.
Fundamental Research in Oncology and Thrombosis 2 (FRONTLINE 2): A Follow-Up Survey
11. Kakkar AK, Bauersachs R, Falanga A, Wong J, Kayani G, Kahney A, Hughes R, Levine M
Oncologist. 2020, Online ahead of print.
Clozapine-induced Anemia: A Case-Report
Eleftheriou G, Butera R, Barcella L, Falanga A.
Int J Clin Pharmacol Ther. 2020;58(5):289-292
Low levels of ADAMTS-13 with high anti-ADAMTS-13 antibodies during remission of immune-mediated thrombotic thrombocytopenic purpura highly predict for disease relapse: A multi-institutional study
Schieppati F, Russo L, Marchetti M, Barcella L, Cefis M, Gomez-Rosas P, Caldara G, Carpenedo M, D’Adda M, Rambaldi A, Savignano C, Billio A, Bruno Franco M, Toschi V, Falanga A (2020).
Am J Hematol. 2020, Online ahead of print.
Anticoagulation in thrombocytopenic patients with hematological malignancy: A multinational clinical vignette-based experiment
Leader A, Ten Cate V, Ten Cate-Hoek AJ, Beckers EAM, Spectre G, Giaccherini C, Gurevich-Shapiro A, Krashin E, Raanani P, Schouten HC, Falanga A, Ten Cate H (2020).
Eur J Intern Med. 2020;77:86-96.
Anticoagulation resumption after intracranial hemorrhage in patients treated with VKA and DOACs
Poli D, Antonucci E, Vignini E, Martinese L, Testa S, Simioni P, Pengo V, Pignatelli P, Falanga A, Masciocco L, Barcellona D, Ciampa A, Chiarugi P, Paparo C, Ageno W, Palareti G, START2 Registry investigators (2020).
Eur J Intern Med. 2020, Online ahead of print.
D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study.
Gualtiero Palareti, Cristina Legnani, Emilia Antonucci, Benilde Cosmi, Daniela Poli, Sophie Testa, Alberto Tosetto, Walter Ageno, Anna Falanga, Piera Maria Ferrini, Vittorio Pengo, Paolo Prandoni, for the DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators.
Intern Emerg Med. 2020; 15(3): 453–462.
Treatment of venous thromboembolism in Northern Italy: A population-based study from 2013 to 2018.
Baviera M, Barcella L, Vannini T, Colacioppo P, Marzona I, Tettamanti M, Merlino L, Fortino I, Morra E, Falanga A, Roncaglioni MC.
Thromb Res. 2020 Epub 2020 Feb 20